United States · FDA National Drug Code directory
Sodium Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-3299_b7a713f4-3c97-484b-b182-2824e1e944bb
- Product NDC
- 0409-3299
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- sodium acetate
- Labeler
- Hospira, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20131119
- Source listing expiry
- 20271231
Source-listed ingredients
- SODIUM ACETATE ANHYDROUS — 164 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CASE (0409-3299-25) / 100 mL in 1 VIAL (0409-3299-45) · 0409-3299-25
- 25 VIAL in 1 TRAY (0409-3299-26) / 50 mL in 1 VIAL (0409-3299-46) · 0409-3299-26
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →